Mackenzie AE

References (2)

Title : The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism - Hudson_2013_Mol.Pharmacol_84_710
Author(s) : Hudson BD , Shimpukade B , Mackenzie AE , Butcher AJ , Pediani JD , Christiansen E , Heathcote H , Tobin AB , Ulven T , Milligan G
Ref : Molecular Pharmacology , 84 :710 , 2013
Abstract : Hudson_2013_Mol.Pharmacol_84_710
ESTHER : Hudson_2013_Mol.Pharmacol_84_710
PubMedSearch : Hudson_2013_Mol.Pharmacol_84_710
PubMedID: 23979972

Title : The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26 - Davoodi_2007_Proteomics_7_2300
Author(s) : Davoodi J , Kelly J , Gendron NH , Mackenzie AE
Ref : Proteomics , 7 :2300 , 2007
Abstract : Davoodi_2007_Proteomics_7_2300
ESTHER : Davoodi_2007_Proteomics_7_2300
PubMedSearch : Davoodi_2007_Proteomics_7_2300
PubMedID: 17549790